FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Clinical trials for FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) explained in plain language.
Never miss a new study
Get alerted when new FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) trials appear
Sign up with your email to follow new studies for FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to keep rare kidney diseases in check
Disease control Recruiting nowThis study tests an injection called BAT4406F in 192 adults with two rare kidney diseases (MCD and FSGS) that cause protein leakage and swelling. The goal is to see if the drug can reduce protein in urine and prevent relapses better than a placebo. Participants must have responde…
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Phase: PHASE2, PHASE3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
Scientists hunt for hidden antibodies in kids with kidney swelling
Knowledge-focused Recruiting nowThis study looks for specific immune system markers (autoantibodies) in the blood and kidney tissue of children with nephrotic syndrome, a condition causing swelling and protein loss. Researchers aim to understand how these markers relate to disease activity and treatment respons…
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Phase: NA • Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC